Senti Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Senti Biosciences generated cash of -$52,395,000, which is less than the previous year. Cash used in financing activities reached the amount of $779,000 last year. Net change in cash is therefore -$21,539,000.
Cash Flow
| 2019 | -18.37M | 3.75M | 14.01M |
|---|---|---|---|
| 2020 | -24.17M | 11.35M | 38.05M |
| 2021 | -34.63M | -5.54M | 68.43M |
| 2022 | -34.89M | -81.95M | 118.55M |
| 2023 | -52.39M | 30.07M | 779K |
SNTI Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 60.98M | 59.29M | 31.03M | 5.79M | 0 |
Operating activities | |||||
Net income | -71.05M | -58.22M | -55.31M | -19.86M | -21.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 5.24M | 3.92M | 3.01M | 1.98M | 1.39M |
Stock-based compensation expense | 9.67M | 16.39M | 2.29M | 272K | 205K |
| Deferred income tax benefit | 9.67M | 16.39M | 2.29M | 272K | 205K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 507K | -131K | -395K | -10K | 124K |
Inventories | 0 | 0 | -205K | -1.60M | 0 |
Accounts payable | -290K | 186K | -617K | -324K | 0 |
Cash generated by operating activities | -52.39M | -34.89M | -34.63M | -24.17M | -18.37M |
Investing activities | |||||
Purchases Of Investments | -17.99M | -40.58M | 0 | -446K | 0 |
Investments In Property Plant And Equipment | -12.03M | -41.37M | -5.54M | -1.16M | -1.99M |
Acquisitions Net | 105K | 0 | 0 | -12.51M | 0 |
Cash generated by investing activities | 30.07M | -81.95M | -5.54M | 11.35M | 3.75M |
Financing activities | |||||
Common Stock Issued | 512K | 728K | 68.45M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -108K | 5.17M | -17K | -8M | 0 |
Cash used in financing activities | 779K | 118.55M | 68.43M | 38.05M | 14.01M |
Net Change In Cash | -21.53M | 1.69M | 28.25M | 25.23M | 5.79M |
Cash at end of period | 39.44M | 60.98M | 59.29M | 31.03M | 5.79M |
| Data source | Data source | Data source |